BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 20889068)

  • 41. Will gene testing cut risk of familial colorectal cancer?
    Lucassen A; Houlston R
    Practitioner; 1998 Apr; 242(1585):306-10, 314. PubMed ID: 10492991
    [No Abstract]   [Full Text] [Related]  

  • 42. Evidence for colorectal cancer screening.
    Bretthauer M
    Best Pract Res Clin Gastroenterol; 2010 Aug; 24(4):417-25. PubMed ID: 20833346
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Colorectal cancer: screening and surveillance in inflammatory bowel diseases - consensus of the working group for inflammatory bowel diseases of the Austrian Society of Gastroenterology and Hepatology].
    Angelberger S; Campregher C; Fuchssteiner H; Gasche C; Gröchenig HP; Haas T; Kazemi-Shirazi L; Mayer A; Miehsler W; Platzer R; Reinisch W; Steiner P; Tilg H; Tillinger W; Vogelsang H; Novacek G
    Z Gastroenterol; 2013 May; 51(5):450-7. PubMed ID: 23681899
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society.
    Winawer SJ; Zauber AG; Fletcher RH; Stillman JS; O'Brien MJ; Levin B; Smith RA; Lieberman DA; Burt RW; Levin TR; Bond JH; Brooks D; Byers T; Hyman N; Kirk L; Thorson A; Simmang C; Johnson D; Rex DK; ;
    Gastroenterology; 2006 May; 130(6):1872-85. PubMed ID: 16697750
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of adenomas among young individuals at average risk for colorectal cancer.
    de Jong AE; Morreau H; Nagengast FM; Mathus-Vliegen EM; Kleibeuker JH; Griffioen G; Cats A; Vasen HF
    Am J Gastroenterol; 2005 Jan; 100(1):139-43. PubMed ID: 15654793
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Colorectal cancer. Measures of prevention].
    Pérez-García R
    Rev Gastroenterol Mex; 2007 Nov; 72 Suppl 2():109-15. PubMed ID: 18277497
    [No Abstract]   [Full Text] [Related]  

  • 47. [Prevention of colorectal cancer in families with hereditary nonpolyposis colorectal cancer].
    Bernstein IT; Bisgaard ML; Myrhøj T
    Ugeskr Laeger; 2003 Jan; 165(3):221-5. PubMed ID: 12555703
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Practice-relevant intestinal diseases: prevention of colon carcinoma].
    Seidensticker F; Schmiegel WH
    Praxis (Bern 1994); 1998 Nov; 87(48):1649-51. PubMed ID: 9881038
    [TBL] [Abstract][Full Text] [Related]  

  • 49. From screening criteria to colorectal cancer screening: what can New Zealand learn from other countries?
    Shaw C; Cunningham R; Sarfati D
    N Z Med J; 2008 Aug; 121(1279):84-95. PubMed ID: 18709051
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hereditary colorectal cancer syndromes.
    Strate LL; Syngal S
    Cancer Causes Control; 2005 Apr; 16(3):201-13. PubMed ID: 15947872
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Development of indicators to evaluate colorectal cancer prevention programs in the high-risk population: the experience of a high-risk colorectal cancer clinic].
    Serra Sutton V; Espallargues M; Balaguer F; Castells A
    Gastroenterol Hepatol; 2012 Nov; 35(9):613-24. PubMed ID: 22749512
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Screening for colorectal cancer.
    Van Cutsem E; Tejpar S; Rutgeerts P; Janssens J
    Acta Gastroenterol Belg; 1995; 58(5-6):397-404. PubMed ID: 8775996
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk stratification for colorectal cancer and implications for screening.
    Tejpar S
    Acta Gastroenterol Belg; 2005; 68(2):241-2. PubMed ID: 16013642
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serrated lesions in colorectal cancer screening: detection, resection, pathology and surveillance.
    East JE; Vieth M; Rex DK
    Gut; 2015 Jun; 64(6):991-1000. PubMed ID: 25748647
    [No Abstract]   [Full Text] [Related]  

  • 55. Recognition and management of hereditary colorectal cancer syndromes.
    Herráiz M; Muñoz-Navas M
    Rev Esp Enferm Dig; 2009 Feb; 101(2):125-32. PubMed ID: 19335048
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Screening for colorectal cancer.
    Kronborg O
    Scand J Surg; 2003; 92(1):20-4. PubMed ID: 12705547
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical end points for developing pharmaceuticals to manage patients with a sporadic or genetic risk of colorectal cancer.
    Rial NS; Zell JA; Cohen AM; Gerner EW
    Expert Rev Gastroenterol Hepatol; 2012 Aug; 6(4):507-17. PubMed ID: 22928902
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Screening for cancerous and precancerous conditions of the colon.
    Julka M; Cherukuri M; Lameh R
    Prim Care; 2011 Sep; 38(3):449-68; viii. PubMed ID: 21872091
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lower Gastrointestinal Conditions: Colorectal Cancer Screening and Prevention.
    McKnight JR
    FP Essent; 2019 Aug; 483():30-35. PubMed ID: 31411847
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The current thinking on colorectal cancer.
    Spreadborough P; Doran C
    J R Nav Med Serv; 2015; 101(1):47-54. PubMed ID: 26292393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.